As the brand drug lobby and other groups asked the conservative 5th Circuit appeals court Wednesday (May 1) to revive their case against Medicare drug price negotiation after a Texas district court said the infusion industry plaintiffs had to appeal to Medicare first, a judge briefly veered off the standing issue and signaled she was sympathetic to an industry argument against the negotiation program.